A fat chance for hepatocyte transplantation?
- Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside? Sancho-Bru, P.; Najimi, M.; Caruso, M.; Pauwelyn, K.; Cantz, T.; Forbes, S.; Roskams, T.; Ott, M.; Gehling, U.; Sokal, E.; Verfaillie, C. M.; Muraca, M. // Gut;Apr2009, Vol. 58 Issue 4, p594
There has been recent progress in the isolation and characterisation of stem/progenitor cells that may differentiate towards the hepatic lineage. This has raised expectations that therapy of genetic or acquired liver disease might be possible by transplanting stem/progenitor cells or their...
- Oral Session: Stem Cell Source and Biology. // Bone Marrow Transplantation;3/2/2003, Vol. 31 Issue 5, pS61
Bone Marrow Transplantation (2003) 31, S61-S64. doi:10.1038/sj.bmt.1703984
- Stem cell transplants. Rowe, Ed // Nursing Standard;11/17/2010, Vol. 25 Issue 11, p58
A quiz on stem cell transplants is presented.
- Double lumen port access in patients receiving allogeneic blood stem cell transplantation. Platzbecker, U; Illmer, T; Schaich, M; Freiberg-Richter, J; Helwig, A; Plettig, R; Jenke, A; Ehninger, G; Bornhäuser, M // Bone Marrow Transplantation;12/1/2001, Vol. 28 Issue 11, p1067
We performed a prospective trial investigating the feasibility of a double lumen port access in 26 patients with hematological malignancies or solid tumors receiving either standard conditioning (n = 9, median age 49 years (range 19â€“65)) or dose-reduced conditioning (n = 17, median age 56...
- New Forms of Transplantation. Handgretinger, R.; Leimig, T.; Babarin-Domer, A.; Holladay, M.A.; Gordon, J. Houston P.; Corbacioglu, S.; Greil, J.; laws, H.; Dilloo, D.; Strahm, B.; Peters, C.; Sykora, K.; Luethy, A. Ridolfi; Friedrich, W.; Gungor, T.; Schulz, A.; Wachowiak, J.; Chybicka, A.; Boruczkowski, D. // Bone Marrow Transplantation;11/1/2002 Supplement, Vol. 30 Issue 9, pS11
Bone Marrow Transplantation (2002) 30, S11â€“S15. doi:10.1038/sj.bmt.1703744
- Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Atsuta, Y.; Suzuki, R.; Yamashita, T.; Fukuda, T.; Miyamura, K.; Taniguchi, S.; Iida, H.; Uchida, T.; Ikegame, K.; Takahashi, S.; Kato, K.; Kawa, K.; Nagamura-Inoue, T.; Morishima, Y.; Sakamaki, H.; Kodera, Y. // Annals of Oncology;Feb2014, Vol. 25 Issue 2, p435
Recipients of allogeneic hematopoietic stem cell transplant had a significantly higher risk of developing secondary solid cancers than the general population. Risk of developing oral/pharynx or esophageal cancer continued to increase with time after transplant. Extensive-type chronic...
- Transplantation of a fetal liver cell-loaded hyaluronic acid sponge onto the mesentery recovers a Wilsonâ€™s disease model rat. Katsuda, Takeshi; Teratani, Takumi; Ochiya, Takahiro; Sakai, Yasuyuki // Journal of Biochemistry;Sep2010, Vol. 148 Issue 3, p281
An auxiliary liver represents a promising alternative for liver transplantation. The use of a large amount of mature hepatocytes, however, despite their high function, is limited in a clinical setting. Here, we propose a novel transplantation system that dramatically improved a diseased animal...
- Magnetic targeting of iron-oxide-labeled fluorescent hepatoma cells to the liver. Luciani, Alain; Wilhelm, Claire; Bruneval, Patrick; Cunin, Patrick; Autret, Gwennhael; Rahmouni, Alain; Clément, Olivier; Gazeau, Florence // European Radiology;May2009, Vol. 19 Issue 5, p1087
The purpose of this study was to determine whether an external magnet field can induce preferential trafficking of magnetically labeled Huh7 hepatoma cells to the liver following liver cell transplantation. Huh7 hepatoma cells were labeled with anionic magnetic nanoparticles (AMNP) and tagged...
- Resolution of late-onset asthma following high-dose chemotherapy. Palmieri, C; Gillmore, R; Menzies-Gow, A; Fishpool, S; Robinson, D; Shaw, R; Coombes, R C // Bone Marrow Transplantation;Oct2003, Vol. 32 Issue 8, p847
Summary:We describe a patient with moderately severe (British Thorax Society Step IV/V) asthma requiring regular inhaled and oral corticosteroids to control symptoms who experienced resolution of her asthma following high-dose chemotherapy and autologous stem cell transplantation for breast...